Skip to content
Open access

Evaluation of the In Vivo Anti-Trypanosomal Activity of the Ethanolic Root Extract of Zingiber officinale in Trypanosoma brucei brucei Infected Mice

Oct 2026 · International Journal of Health and Pharmaceutical Research · 0 citations

Abstract

African trypanosomiasis remains a significant public health and veterinary challenge in subSaharan Africa, complicated by limitations of existing chemotherapeutics, including toxicity and drug resistance. Medicinal plants such as Zingiber officinale (ginger) represent a potential source of novel anti trypanosomal agents. This study investigated the in vivo anti-trypanosomal activity of the ethanolic root extract of Zingiber officinale against Trypanosoma brucei brucei in mice. Methodology: The root of Z. officinale was macerated in 70% ethanol, yielding a 3.75% extract. An acute toxicity test was conducted using Lorke's method. The anti-trypanosomal activity was evaluated in four-day suppressive, curative, and prophylactic (repository) tests inT. b. bruceiinfected mice. Mice were treated with the extract at 100, 200, and 400 mg/kg body weight, with diminazene aceturate (5 mg/kg) and normal saline (5 ml/kg) serving as positive and negative controls, respectively. Parasitemia levels and mean survival time were monitored. Results: The acute toxicity test established an oral LD₅₀ of 3,353 mg/kg, indicating a wide safety margin. Phytochemical screening revealed the presence of carbohydrates, flavonoids, tannins, and alkaloids. In the suppressive test, the extract produced a dose-dependent chemosuppression of 58.3%, 62.3%, and 82.6% at 100, 200, and 400 mg/kg, respectively, compared to 98.2% for diminazene. In the curative test, the extract demonstrated percentage reductions in parasitemia of 44.0%, 50.8%, and 78.3% at the same doses, versus 95.4% for the standard drug. The prophylactic test revealed a repository effect with suppressions of 49.0%, 49.9%, and 81.0% for the extract, compared to 97.6% for diminazene. Conclusion: The ethanolic root extract of Zingiber officinale possesses significant dosedependent anti-trypanosomal activity in murine models, substantiating its traditional use. These findings justify further investigation into the isolation of the active compounds and their mechanisms of action.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.